Desmopressin EP Dydrogesterone Impurity B is a recognized impurity standard associated with desmopressin formulations. Variations in oxidation or processing conditions generate measurable changes in chromatographic signature. Researchers use it to evaluate specificity of impurity-profiling methods. Applications include stability-indicating assay development, impurity assignment, and structural characterization.
CAT No: R2765
CAS No:1162-56-7
Synonyms/Alias:6-Dehydroprogesterone; Pregna-4,6-diene-3,20-dione; 1162-56-7; Delta-6-progesterone; .delta.6-Progesterone; 4,6-Pregnadiene-3,20-dione; Dydrogesterone impurity B; UNII-EF38VA583P; delta6-Progesterone; EF38VA583P; 6-Dehydropregesteron; (8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one; PROGESTERONE IMPURITY H [EP IMPURITY]; DYDROGESTERONE IMPURITY B [EP IMPURITY]; MFCD00199858; PROGESTERONE IMPURITY H (EP IMPURITY); DYDROGESTERONE IMPURITY B (EP IMPURITY); SCHEMBL606817; Pregna-4,6-diene-3,20-dione (Delta6-Progesterone); CHEMBL4101936; BCP18804; AKOS015902046; AC-4529; FD32696; AS-15619; CS-0155158; P2623; Pregna-4,6-diene-3,20-dione (?6-Progesterone); Q27277145
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.